Skip to content
Unrated Drug recall · FDA · Published December 18, 2017

Osmotica Methylphenidate Tablets Recall: Subpotent Drug Risk

Osmotica Pharmaceutical Corp recalls 27mg methylphenidate tablets due to subpotent drug levels. Affected products have NDC 13811-707-10 and lot 170027A. No remedy specified in recall notice.

🇺🇸 FDA recall #D-0110-2018DrugOsmot: Trigen Laboratories ›
Take action

Contact the company

Recalling firmOsmotica Pharmaceutical Corp895 Sawyer Rd · Marietta, GA 30062-2257
✎ GovInfoNow plain-language explainer

Osmotica Pharmaceutical Corp is recalling 27mg methylphenidate hydrochloride extended-release tablets that may contain less active ingredient than labeled. This could lead to inadequate treatment for ADHD or other conditions requiring the medication. Read more at govinfonow.com/recall/41010-osmotica-methylphenidate-tablets-recall-subpotent-drug-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/41010-osmotica-methylphenidate-tablets-recall-subpotent-drug-risk · Updated October 7, 2026 · FDA enforcement record: FDA #D-0110-2018

Cite this page

“Osmotica Methylphenidate Tablets Recall: Subpotent Drug Risk.” GovInfoNow, updated October 7, 2026. https://govinfonow.com/recall/41010-osmotica-methylphenidate-tablets-recall-subpotent-drug-risk. Based on FDA recall #D-0110-2018 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0110-2018%22&limit=1).

Osmotica Pharmaceutical Corp recalled Methylphenidate Hydrochloride Extended-release Tablets, USP 27 mg, 100-count bottles from Trigen Laboratories due to subpotent drug risks, the FDA said on Dec. 18, 2017.

How to tell if you have it

  • Brand: Osmot: Trigen Laboratories
  • Product: Methylphenidate Hydrochloride Extended-release Tablets, USP 27 mg, 100-count bottles
  • NDC: 13811-707-10
  • Lot #: 170027A
  • Expiration: 02/2019

The hazard

The recall involves subpotent drug risks associated with the affected Methylphenidate Hydrochloride Extended-release Tablets, USP 27 mg.

Context

GovInfoNow's records show Osmotica Pharmaceutical Corp has issued two other recalls since Sept. 16, 2013, including a Feb. 28, 2018 recall of Methylphenidate Tablets 36mg for subpotent drug risk and a Sept. 16, 2013 recall of Venlafaxine 225mg due to dissolution failure. Other recent recalls of similar products include Unichem busPIRone 5mg Tablets Recall (April 13, 2026), Major Pharmaceuticals Levothyroxine Tablets Recall (July 13, 2026), and Macleods Levothyroxine Tablets Recall (Feb. 26, 2026).

How to tell if you have this one

Check for NDC code 13811-707-10 and lot number 170027A on the product label. These tablets are prescription-only and sold by Trigen Laboratories in Bridgewater, NJ.

  • Brand
    Osmot: Trigen Laboratories
  • Category
    Drug
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class III
  • Status
    Terminated
  • Distribution
    Nationwide
  • NDC
    13811-709-10, 13811-706-10, 13811-707-10, 13811-708-10, 13811-710-10, 13811-710-30
Recall numberProduct, codes & lotsQuantity
D-0110-2018Methylphenidate Hydrochloride Extended-release Tablets, USP 27 mg, 100-count bottles, Rx Only, Trigen Laboratories, LLC. Bridgewater, NJ 08807, NDC 13811-707-10; Lot #: 170027A, Exp. 02/201910064 bottles
D-0111-2018Methylphenidate Hydrochloride Extended-release Tablets, USP 54 mg, 100-count bottles, Rx Only, Trigen Laboratories, LLC. Bridgewater, NJ 08807, NDC 13811-709-10; Lot #: 170029A, Exp. 02/2019; 170030A, Exp. 02/20199919 bottles
Based on the official FDA remedy

What to do — step by step

  1. Check Product Label

    Look for NDC 13811-707-10 and lot number 170027A on the tablet packaging.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 16 months after the firm started it.

1. Firm started the recall: Dec 18, 201712. FDA classified it Class III: Dec 20, 201723. Published in FDA’s Enforcement Report: Dec 27, 201734. FDA terminated the recall: May 1, 2019420172019
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Are there any safety risks from using these tablets?

The recall indicates potential treatment failure, but no specific safety risks like injury are mentioned.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0110-2018 (December 18, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0110-2018 to see it in context.
  • Plain-language summary written by qwen3:4b on October 7, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA